May 22, 2023 — Findings from two new studies highlight the success of left bundle branch area pacing (LBBAP), or his-bundle pacing (HBP) as an alternative to biventricular pacing (BVP) for patients ...
Cardiac Resynchronization Therapy Devices (CRT)
Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.
-
-
May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization therapy (CRT) among patients who were not able to be treated with conventional CRT ...
-
August 19, 2022 — According to a release just issued by the U.S. Food and Drug Administration (FDA), Medtronic is recalling Cobalt/Crome Implantable Cardioverter Defibrillators (ICDs) and ...
-
Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world analysis of U.S. Centers for Medicare & Medicaid Services (CMS) data on the rates of ...
May 22, 2023
May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization ...
May 22, 2023
Arrhythmias can be described as irregular heart rhythms that are brought on by numerous factors, including heart damage ...
August 23, 2022
August 19, 2022 — According to a release just issued by the U.S. Food and Drug Administration (FDA), Medtronic is ...
August 19, 2022
Royal Philips, a global leader in health technology, announced late-breaking results of a large-scale, real-world ...
April 12, 2022
Feature | By Dave Fornell, DAIC Editor
November 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
November 01, 2021
With 1.2 to 1.4 million new electrophysiology (EP) devices being prescribed to patients around the world each year ...
October 28, 2021
October 27, 2021 — EBR Systems Inc., developer of the world’s first wireless cardiac pacing system for heart failure, ...
October 27, 2021
October 1, 2021 — The European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization ...
October 04, 2021
Khaldoun Tarakji, M.D., MPH, associate section head, cardiac electrophysiology, Heart and Vascular Institute at ...
October 04, 2021
September 13, 2021 — Ablation plus cardiac resynchronization therapy (CRT) is superior to pharmacological rate control ...
September 13, 2021
August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO ...
August 03, 2021
Samir Saba, M.D., co-director of the University of Pittsburgh Medical Center Heart and Vascular Institute, and chief ...
August 02, 2021
July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27 ...
July 28, 2021![Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.](/sites/default/files/styles/content_feed_medium/public/X0000_Tyrx_AIGISRx_Envelope_with_Pacemaker.jpg?itok=BHsWJ9_y)
July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...
July 27, 2021© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now